Atricure Inc 7555 Innovation Waywest Chester Oh 45040 Pma Numberp200002 Supplement Numbers004 Date Received09 28 2022 Decision Date12 27 2022 Product Code Ocm Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track Supplement Reason Change Design Components Specifications Material Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Atricure Inc 7555 Innovation Waywest Chester Oh 45040 Pma Numberp200002 Supplement Numbers004 Date Received09 28 2022 Decision Date12 27 2022 Product Code Ocm Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track Supplement Reason Change Design Components Specifications Material Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P200002S004 AtriCure, Inc.7555 Innovation Waywest Chester, OH 45040 PMA NumberP200002 Supplement NumberS004 Date Received09/28/2022 Decision Date12/27/2022 Product Code OCM  Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track Supplement Reason Change Design/components/specifications/material Expedited Review Granted? No	EPi-Sense®, EPi-Sense ST™ Guided Coagulation System	2022-12-27